Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.01% Eye Drops for Myopia in Children
NCT07456488Phase 2Recruiting
- Sponsor
- Liaquat National Hospital & Medical College
- Start
- Jul 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of NVK002 in myopia (2 arms), sponsored by Liaquat National Hospital & Medical College. Primary endpoints: Change in axial length at 6 months and Change in refraction at 6 months. Started Jul 2025; status: recruiting.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT07456488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456488.